Induction of sustained patency after clot-selective coronary thrombolysis with Hybrid-B, a genetically engineered plasminogen activator with a prolonged biological half-life.Carla J. Weinheimer, Steven R. Bergmann, S G Lee et al.|Circulation|1991Cited by 12
Biological Properties of Hybrid Plasminogen ActivatorsP.P. Hung, Steven R. Bergmann, J Wilhelm et al.|Advances in experimental medicine and biology|1990Cited by 0